Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Justin Kim's Stock Ratings
Oppenheimer Analyst
Justin Kim is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
-8.13%
Smart Score
Overall Average Return Percentile
20th
Number of Ratings
46
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/04/2025 | PHVS | Buy Now | Pharvaris | $24.38 | 105.09% | $44 → $50 | Maintains | Outperform | Get Alert | |
| 08/15/2025 | ZURA | Buy Now | Zura Bio | $4.18 | 282.32% | $17 → $16 | Maintains | Outperform | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | 64.24% | $65 → $40 | Maintains | Outperform | Get Alert | |
| 09/06/2024 | PHVS | Buy Now | Pharvaris | $24.38 | 72.27% | $38 → $42 | Maintains | Outperform | Get Alert | |
| 07/03/2024 | PHVS | Buy Now | Pharvaris | $24.38 | 55.87% | $36 → $38 | Maintains | Outperform | Get Alert | |
| 05/09/2024 | CYTK | Buy Now | Cytokinetics | $61.29 | 72.95% | $107 → $106 | Maintains | Outperform | Get Alert | |
| 03/04/2024 | CYTK | Buy Now | Cytokinetics | $61.29 | 74.58% | → $107 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/29/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.26 | 139.93% | $85 → $87 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/30/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | 224.37% | $75 → $79 | Maintains | Outperform | Get Alert | |
| 01/25/2024 | VERA | Buy Now | Vera Therapeutics | $49.00 | -46.94% | → $26 | Initiates | → Outperform | Get Alert | |
| 12/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | 207.94% | $88 → $75 | Maintains | Outperform | Get Alert | |
| 10/17/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $5.22 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 09/21/2023 | IMCR | Buy Now | Immunocore Hldgs | $36.26 | 134.42% | $75 → $85 | Maintains | Outperform | Get Alert | |
| 08/25/2023 | ZURA | Buy Now | Zura Bio | $4.18 | 306.21% | → $17 | Initiates | → Outperform | Get Alert | |
| 08/23/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | — | — | Reiterates | Outperform → Outperform | Get Alert | |
| 08/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $36.26 | 106.84% | $72 → $75 | Maintains | Outperform | Get Alert | |
| 08/09/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $5.22 | 168.26% | → $14 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/16/2023 | CYTK | Buy Now | Cytokinetics | $61.29 | -11.89% | → $54 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/12/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | 343.44% | $96 → $108 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | CYTK | Buy Now | Cytokinetics | $61.29 | -11.89% | $55 → $54 | Maintains | Outperform | Get Alert | |
| 02/28/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $33 → $34 | Maintains | Outperform | Get Alert | |
| 02/21/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $28 → $33 | Maintains | Outperform | Get Alert | |
| 02/15/2023 | IMCR | Buy Now | Immunocore Hldgs | $36.26 | 98.57% | $65 → $72 | Maintains | Outperform | Get Alert | |
| 11/18/2022 | PRVB | Buy Now | Provention Bio | — | — | $14 → $18 | Maintains | Outperform | Get Alert | |
| 11/04/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $24.38 | -9.76% | $48 → $22 | Maintains | Outperform | Get Alert | |
| 08/18/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $24.36 | 220.26% | $68 → $78 | Maintains | Outperform | Get Alert | |
| 08/08/2022 | BCRX | Buy Now | BioCryst Pharma | $7.61 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 08/08/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | -16.99% | $15 → $13 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | BCRX | Buy Now | BioCryst Pharma | $7.61 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 07/18/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $78.07 | -24.43% | → $59 | Assumes | → Outperform | Get Alert | |
| 06/30/2022 | ANGN | Buy Now | Angion Biomedica | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/11/2022 | BCRX | Buy Now | BioCryst Pharma | $7.61 | 110.21% | $20 → $16 | Maintains | Outperform | Get Alert | |
| 12/22/2021 | CYTK | Buy Now | Cytokinetics | $61.29 | -10.26% | → $55 | Initiates | → Outperform | Get Alert | |
| 12/10/2021 | ANGN | Buy Now | Angion Biomedica | — | — | $15 → $8 | Maintains | Outperform | Get Alert | |
| 12/10/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | 97.96% | $33 → $31 | Upgrade | Perform → Outperform | Get Alert | |
| 12/10/2021 | BCRX | Buy Now | BioCryst Pharma | $7.61 | 110.21% | → $16 | Initiates | → Outperform | Get Alert | |
| 11/04/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | 110.73% | $32 → $33 | Maintains | Perform | Get Alert | |
| 10/28/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | 104.34% | $28 → $32 | Downgrade | Outperform → Perform | Get Alert | |
| 10/20/2021 | IMCR | Buy Now | Immunocore Hldgs | $36.26 | 54.44% | → $56 | Initiates | → Outperform | Get Alert | |
| 08/06/2021 | PRVB | Buy Now | Provention Bio | — | — | $18 → $16 | Maintains | Outperform | Get Alert | |
| 03/02/2021 | PHVS | Buy Now | Pharvaris | $24.38 | 96.88% | → $48 | Initiates | → Outperform | Get Alert | |
| 03/02/2021 | ANGN | Buy Now | Angion Biomedica | — | — | → $38 | Initiates | → Outperform | Get Alert | |
| 06/04/2020 | PRVB | Buy Now | Provention Bio | — | — | → $29 | Initiates | → Outperform | Get Alert | |
| 09/10/2019 | AUPH | Buy Now | Aurinia Pharmaceuticals | $15.66 | -10.6% | → $14 | Initiates | → Outperform | Get Alert | |
| 02/27/2014 | BCRX | Buy Now | BioCryst Pharma | $7.61 | — | — | Initiates | → Perform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved